Collegium Pharmaceutical, Inc
COLL· Nasdaq
COLLCollegium Pharmaceutical, Inc
Filed Mar 10, 2017 · 10-K · 69 days after period end · 0001558370-17-001629
| Metric | Q4 2016 | Q4 2015 | Q4 2014 |
|---|---|---|---|
| Revenue | $1.30M | — | — |
| Net Income | -$27.56M | -$9.53M | -$3.47M |
| EPS Diluted | -$1.02 | -$0.46 | -$4.50 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Collegium Pharmaceutical, Inc · CIK 1267565 · Engraved from SEC EDGAR
ended Dec 31, 2016 · filed Mar 10, 2017 · 69 d after period end
